BPC-157 vs MOTS-c vs TB-500

A three-way comparison to help you find the right peptide for your research goals.

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a mitochondrial-derived peptide that plays a key role in metabolic regulation and has emerged as a significant longevity research target.

Full details →

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

Side-by-Side Comparison

Aspect	BPC-157	MOTS-c	TB-500
Dose Range	250 mcg–500 mcg	5 mg–10 mg	2 mg–2.5 mg
Frequency	2x daily	Less than daily	Less than daily
Cycle Length	4–6 weeks	8–12 weeks	4–8 weeks
Route	subcutaneous	subcutaneous	subcutaneous
Mechanism	BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.	Activates AMPK pathway, enhances glucose uptake in skeletal muscle, improves insulin sensitivity, and regulates mitochondrial function. Acts as a metabolic hormone affecting whole-body energy homeostasis.	TB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.
Typical Dosage	Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.	Research protocols typically use 5-10mg administered subcutaneously several times per week. Optimal dosing not yet established.	Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.
Administration	Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.	Subcutaneous injection. Often combined with exercise protocols as it enhances exercise capacity and metabolic adaptation.	Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.
Side Effects	Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.	Limited human data. Animal studies show good tolerability. May affect energy levels and exercise performance.	May cause temporary fatigue, headache, or localized irritation at injection sites.
Best For	Muscle Growth Recovery & Healing	Muscle Growth Fat Loss Anti-Aging & Longevity	Muscle Growth Recovery & Healing